Drug‐Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker‐Informed Approach
Sumathy Mathialagan, Bo Feng, A. David Rodrigues, Manthena V. S. Varma
Abstract
The authors declared no competing interests for this work. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
BiomarkerDrugEndogenyTransporterPharmacologyComputer scienceMedicineChemistryInternal medicineBiochemistryGeneDrug Transport and Resistance MechanismsRenal and related cancersDiabetes Treatment and Management